WorldQuant Millennium Advisors
ABBV icon

WorldQuant Millennium Advisors’s AbbVie ABBV Stock Holding History

WorldQuant Millennium Advisors’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$117M Sell
536,277
-265,519
-33% -$58.9M 0.45% 55
2025
Q4 		$183M Buy
801,796
+88,941
+12% +$20.3M 0.71% 27
2025
Q3 		$165M Sell
712,855
-422,179
-37% -$86M 0.71% 30
2025
Q2 		$211M Buy
1,135,034
+612,702
+117% +$114M 1.05% 18
2025
Q1 		$109M Buy
522,332
+105,981
+25% +$20.6M 0.69% 33
2024
Q4 		$74M Sell
416,351
-161,765
-28% -$29.7M 0.48% 55
2024
Q3 		$114M Buy
578,116
+348,697
+152% +$65.1M 0.84% 25
2024
Q2 		$39.3M Buy
+229,419
New +$38M 0.36% 87
2024
Q1 		– Sell
-253,194
Closed -$39.2M – 347
2023
Q4 		$39.2M Sell
253,194
-55,060
-18% -$8.03M 0.55% 53
2023
Q3 		$45.9M Buy
308,254
+3,849
+1% +$565K 0.71% 30
2023
Q2 		$41M Buy
+304,405
New +$44.6M 0.69% 28
2021
Q3 		– Sell
-15,797
Closed -$1.78M – 318
2021
Q2 		$1.78M Buy
+15,797
New +$1.78M 0.04% 255
2020
Q3 		– Sell
-162,377
Closed -$15.9M – 330
2020
Q2 		$15.9M Sell
162,377
-50,330
-24% -$4.43M 0.37% 92
2020
Q1 		$16.2M Buy
212,707
+73,146
+52% +$6.23M 0.39% 81
2019
Q4 		$12.4M Sell
139,561
-390,266
-74% -$32.4M 0.24% 140
2019
Q3 		$40.1M Buy
529,827
+260,122
+96% +$17.8M 0.78% 34
2019
Q2 		$19.6M Buy
269,705
+45,531
+20% +$3.58M 0.37% 101
2019
Q1 		$18.1M Buy
224,174
+22,965
+11% +$1.88M 0.43% 90
2018
Q4 		$18.5M Sell
201,209
-36,512
-15% -$3.21M 0.55% 59
2018
Q3 		$22.5M Buy
237,721
+10,315
+5% +$978K 0.75% 37
2018
Q2 		$21.1M Buy
+227,406
New +$22.2M 0.81% 39

Other funds holding ABBV

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

WorldQuant Millennium Advisors's ABBV Position: Q1 2026 in Review

WorldQuant Millennium Advisors reduced its AbbVie (ABBV) stake by 33% in Q1 2026, selling an estimated $58.9M and leaving 536,277 shares worth $117M. The position accounts for 0.45% of the portfolio, ranked #55.

WorldQuant Millennium Advisors first reported a position in ABBV in Q2 2018 and has held it in 21 quarters since. The position peaked at $211M in Q2 2025. 4,075 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.

  • WorldQuant Millennium Advisors held 536,277 shares of AbbVie worth $117M as of Q1 2026.
  • WorldQuant Millennium Advisors sold 265,519 AbbVie shares in Q1 2026, an estimated $58.9M.
  • AbbVie made up 0.45% of WorldQuant Millennium Advisors's portfolio in Q1 2026, its #55 holding.
  • WorldQuant Millennium Advisors first reported a position in AbbVie in Q2 2018 and has held it in 21 quarters since.
  • WorldQuant Millennium Advisors's AbbVie position peaked at $211M in Q2 2025.
  • 4,075 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.

Based on WorldQuant Millennium Advisors's 13F filing for Q1 2026, filed 15 May 2026.